Cargando…
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Despite the remarkable success of immune checkpoint inhibitors (ICIs), primary resistance to ICIs causes only subsets of patients to achieve durable responses due to the complex tumor microenvironment (TME). Oncolytic viruses (OVs) can overcome the immunosuppressive TME and promote systemic antitumo...
Autores principales: | Xie, Daoyuan, Tian, Yaomei, Hu, Die, Wang, Yuanda, Yang, Yuling, Zhou, Bailing, Zhang, Rui, Ren, Zhixiang, Liu, Mohan, Xu, Jie, Dong, Chunyan, Zhao, Binyan, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684539/ https://www.ncbi.nlm.nih.gov/pubmed/38016957 http://dx.doi.org/10.1038/s41392-023-01683-2 |
Ejemplares similares
-
Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo
por: Zhao, Binyan, et al.
Publicado: (2021) -
A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy
por: Zhang, Rui, et al.
Publicado: (2023) -
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
por: Tian, Yaomei, et al.
Publicado: (2022) -
Rational design of innate defense regulator peptides as tumor vaccine adjuvants
por: Tian, Yaomei, et al.
Publicado: (2021) -
Sustained and targeted delivery of siRNA/DP7‐C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy
por: Zhao, Binyan, et al.
Publicado: (2021)